CD274 and head and neck squamous cell carcinoma: Compared to ChatGPT 4.0, immunotherapy was never a therapy option of Claude 3 for the patients in this study of primary HNSCC as a therapy option, while ChatGPT 4.0 recommended immunotherapy for patients without regard to the PD-L1 status or combined positive score (CPS).